Market Tracker

07/29 12:49pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

232.62
Data as of 12:34pm ET
 +8.63 / +3.85%
Today’s Change
42.41
Today|||52-Week Range
497.00
+240.69%
Year-to-Date

Today’s Trading

Previous close223.99
Today’s open225.50
Day’s range225.50 - 238.56
Volume198,996
Average volume (3 months)470,895
Market cap$4.7B
Dividend yield--
Data as of 12:34pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-289.58%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book52.70

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+6.94+7.64%
MNKMallinckrodt Plc-0.92-1.26%
SGENSeattle Genetics Inc+0.86+2.50%
QCORQuestcor Pharmaceuti...-0.93-0.99%
Data as of 12:46pm ET, 07/29/2014

Financials

Next reporting dateAugust 12, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts